William M Sellers
age ~55
from Hingham, MA
- Also known as:
-
- William L Sellers
- William W Sellers
- Bill M Sellers
- Wm Sellers
William Sellers Phones & Addresses
- Hingham, MA
- Charlestown, MA
- Cambridge, MA
- Reading, MA
- Winchester, MA
- Somerville, MA
- Canton, MA
- Townsend, MA
Name / Title
Company / Classification
Phones & Addresses
Family And General Dentistry
Lisa Vouras DMD
Dentists' Office · Dentists
Dentists' Office · Dentists
85 Woburn St, Reading, MA 01867
781 944-4940
781 944-4940
EMERALD HILLS PASTURE, LTD
William Sellers MD
Internist
Internist
250 Massachusetts Ave, Cambridge, MA 02139
617 871-3938
617 871-3938
SPRINGHILL GROUP LTD
BLUE GILL RENTALS, LTD
A. KNIGHT HAWK SECURITY LC
President
LEADING EDGE VENTURES, INC
225 Tpke St, Canton, MA 02021
19 Cardinal St, Winchester, MA
19 Cardinal St, Winchester, MA
President
LEADING EDGE WORLD TRADE SINGAPORE, INC
35 Highland Cir, Needham, MA 02194
19 Cardinal St, Winchester, MA
19 Cardinal St, Winchester, MA
Medicine Doctors
Dr. William R Sellers, Cambridge MA - MD (Doctor of Medicine)
view sourceSpecialties:
Oncology
Medical Oncology
Medical Oncology
Address:
250 Massachusetts Ave, Cambridge, MA 02139
617 871-3938 (Phone)
617 871-3938 (Phone)
Certifications:
Internal Medicine, 1989
Medical Oncology, 1993
Medical Oncology, 1993
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Massachusetts / Worcester Campus
Graduated: 1986
Medical School
University Of California-San Francisco
Graduated: 1986
Medical School
Dana Farber Canc Inst-Harva
Graduated: 1986
University of Massachusetts / Worcester Campus
Graduated: 1986
Medical School
University Of California-San Francisco
Graduated: 1986
Medical School
Dana Farber Canc Inst-Harva
Graduated: 1986
Dr. William W Sellers, Reading MA - DMD (Doctor of Dental Medicine)
view sourceSpecialties:
Dentistry
Address:
85 Woburn St, Reading, MA 01867
781 944-4940 (Phone), 781 944-0445 (Fax)
781 944-4940 (Phone), 781 944-0445 (Fax)
Languages:
English
Education:
Medical School
No Information Available As To Scientific Medical Education
No Information Available As To Scientific Medical Education
William D. Sellers
view sourceSpecialties:
Pediatrics
Work:
Winston Salem Pediatrics
2808 Maplewood Ave STE 308, Winston Salem, NC 27103
336 765-9000 (phone), 336 765-5702 (fax)
2808 Maplewood Ave STE 308, Winston Salem, NC 27103
336 765-9000 (phone), 336 765-5702 (fax)
Languages:
English
Spanish
Spanish
Description:
Mr. Sellers works in Winston-Salem, NC and specializes in Pediatrics. Mr. Sellers is affiliated with Novant Health Forsyth Medical Center and Wake Forest Baptist Medical Center.
William Raj Sellers
view sourceSpecialties:
Internal Medicine
Medical Oncology
Medical Oncology
Education:
University of Massachusetts (1986)
License Records
William Sellers
License #:
4506 - Expired
Category:
Architecture
Issued Date:
Jun 10, 2009
Expiration Date:
Nov 30, 2011
William Sellers
Address:
Boston, MA 02115
License #:
70699 - Expired
Issued Date:
Aug 1, 1985
Expiration Date:
Jul 16, 1987
Type:
Salesperson
William O Sellers
License #:
RS085689A - Expired
Category:
Real Estate Commission
Type:
Real Estate Salesperson-Standard
Resumes
Professor Of Medicine
view sourceLocation:
50 Cleveland Rd, Chestnut Hill, MA 02467
Industry:
Pharmaceuticals
Work:
Harvard Medical School and Dana-Farber Cancer Institute
Professor of Medicine
Broad Institute
Core Faculty Member
Novartis Institutes For Biomedical Research (Nibr) Oct 2005 - Sep 2016
Vice President and Global Head of Oncology
Broad Institute Jan 2001 - Oct 2005
Associate Member
Dana-Farber Cancer Institute Jul 1990 - Oct 2005
Associate Professor of Medicine
Professor of Medicine
Broad Institute
Core Faculty Member
Novartis Institutes For Biomedical Research (Nibr) Oct 2005 - Sep 2016
Vice President and Global Head of Oncology
Broad Institute Jan 2001 - Oct 2005
Associate Member
Dana-Farber Cancer Institute Jul 1990 - Oct 2005
Associate Professor of Medicine
Education:
University of Massachusetts Medical School 1982 - 1986
Doctor of Medicine, Doctorates, Medicine Georgetown University 1978 - 1982
Bachelors, Bachelor of Science, Biology
Doctor of Medicine, Doctorates, Medicine Georgetown University 1978 - 1982
Bachelors, Bachelor of Science, Biology
Skills:
Biotechnology
Life Sciences
Oncology
Molecular Biology
Cancer
Drug Discovery
Pharmaceutical Industry
Clinical Trials
Drug Development
Life Sciences
Oncology
Molecular Biology
Cancer
Drug Discovery
Pharmaceutical Industry
Clinical Trials
Drug Development
William Sellers
view sourceLocation:
Newton, MA
Industry:
Pharmaceuticals
Work:
Putnam Associates Jun 1, 2014 - Aug 2014
Summer Associate
Novartis Jun 2013 - Aug 2013
Brand Team Intern
Pro Partner Sports Management Dec 2012 - May 2013
Intern
Consumer Behavior Research Co.,Ltd. Jun 2012 - Aug 2012
Quantitative Research Intern
Summer Associate
Novartis Jun 2013 - Aug 2013
Brand Team Intern
Pro Partner Sports Management Dec 2012 - May 2013
Intern
Consumer Behavior Research Co.,Ltd. Jun 2012 - Aug 2012
Quantitative Research Intern
Education:
Tufts University 2011 - 2015
Bachelors, Bachelor of Science, Economics Phillips Exeter Academy 2010 - 2011
Brookline High School 2007 - 2010
Bachelors, Bachelor of Science, Economics Phillips Exeter Academy 2010 - 2011
Brookline High School 2007 - 2010
Skills:
Microsoft Office
Microsoft Word
Data Analysis
Research
Microsoft Excel
Market Research
Microsoft Word
Data Analysis
Research
Microsoft Excel
Market Research
Assistant Vice President Financial Services And Insurance
view sourceLocation:
11 Ship St, Hingham, MA 02043
Industry:
Market Research
Work:
Adobe
Assistant Vice President Financial Services and Insurance
Adobe
Financial Services Industry - Banking Lead
Neo Group Nov 1, 2014 - Apr 2017
Senior Vice President and Partner
Eduventures Jan 2013 - Oct 2014
Managing Vice President Sales and Business Development
Masergy 2014 - 2014
Sales Consultant
Assistant Vice President Financial Services and Insurance
Adobe
Financial Services Industry - Banking Lead
Neo Group Nov 1, 2014 - Apr 2017
Senior Vice President and Partner
Eduventures Jan 2013 - Oct 2014
Managing Vice President Sales and Business Development
Masergy 2014 - 2014
Sales Consultant
Education:
Arizona State University 1989 - 1992
Bachelors, Pre Law, Political Science, Communications Northeastern University 1988 - 1989
Bachelors, Pre Law, Political Science, Communications Northeastern University 1988 - 1989
Skills:
Competitive Analysis
Business Development
Strategy
Customer Insight
Management
Analytics
Saas
Lead Generation
Segmentation
Leadership
Crm
Strategic Partnerships
Sales Process
Sales Management
Marketing
Vertical Marketing
Sales Operations
Marketing Strategy
B2B
Fmcg
Digital Strategy
Sales and Marketing Leadership
Online Marketing
Web Analytics
Direct Marketing
Business Development
Strategy
Customer Insight
Management
Analytics
Saas
Lead Generation
Segmentation
Leadership
Crm
Strategic Partnerships
Sales Process
Sales Management
Marketing
Vertical Marketing
Sales Operations
Marketing Strategy
B2B
Fmcg
Digital Strategy
Sales and Marketing Leadership
Online Marketing
Web Analytics
Direct Marketing
Interests:
Health
William Sellers
view source
William Sellers
view source
William Pete Sellers
view sourceUs Patents
-
Prostate Cancer Diagnosis And Outcome Prediction By Expression Analysis
view source -
US Patent:6949342, Sep 27, 2005
-
Filed:Dec 19, 2002
-
Appl. No.:10/325457
-
Inventors:Todd R. Golub - Newton MA, US
Phillip G. Febbo - Jamaica Plain MA, US
Kenneth N. Ross - Boston MA, US
William R. Sellers - Chestnut Hill MA, US -
Assignee:Whitehead Institute for Biomedical Research - Cambridge MA
Dana-Farber Cancer Institute, Inc. - Boston MA -
International Classification:C12Q001/68
G01N033/53 -
US Classification:435 6, 435 71
-
Abstract:Methods identifying prostate cancer, methods for prognosing and diagnosing prostate cancer, methods for identifying a compound that modulates prostate cancer development, methods for determining the efficacy of a prostate cancer therapy, and oligonucleotide microarrays containing probes for genes involved in prostate cancer development are described.
-
Method To Determine Responsiveness Of Cancer To Epidermal Growth Factor Receptor Targeting Treatments
view source -
US Patent:7294468, Nov 13, 2007
-
Filed:Dec 5, 2005
-
Appl. No.:11/294621
-
Inventors:Daphne Winifred Bell - Arlington MA, US
Daniel A. Haber - Chestnut Hill MA, US
Pasi Antero Janne - Newton MA, US
Bruce E. Johnson - Brookline MA, US
Thomas J. Lynch - Newton MA, US
Matthew Meyerson - Concord MA, US
Juan Guillermo Paez - Boston MA, US
William R. Sellers - Chestnut Hill MA, US
Jeffrey E. Settleman - Newton MA, US
Raffaella Sordella - Bedford MA, US -
Assignee:The General Hospital Corporation - Boston MA
Dana-Farber Cancer Institute, Inc. - Boston MA -
International Classification:C12Q 1/68
-
US Classification:435 6, 424 91, 435 912
-
Abstract:The present invention is directed to a method for determining the responsiveness of cancer to an epidermal growth factor receptor (EGFR) treatment. In a preferred embodiment, the presence of at least one variance in the kinase domain of the erbB1 gene confers sensitivity to the tyrosine kinase inhibitor gefitinib. Thus, a diagnostic assay for these mutations will allow for the administration of gefitinib, erlotinib and other tyrosine kinase inhibitors to those patients most likely to respond to the drug.
-
Prostate Cancer Diagnosis And Outcome Prediction By Expression Analysis
view source -
US Patent:7501248, Mar 10, 2009
-
Filed:Sep 26, 2005
-
Appl. No.:11/236702
-
Inventors:Todd R. Golub - Newton MA, US
Phillip G. Febbo - Jamaica Plain MA, US
Kenneth N. Ross - Boston MA, US
William R. Sellers - Chestnut Hill MA, US -
Assignee:Whitehead Institute for Biomedical Research - Cambridge MA
Dana-Farber Cancer Institute, Inc. - Boston MA -
International Classification:C12Q 1/68
-
US Classification:435 6
-
Abstract:Methods identifying prostate cancer, methods for prognosing and diagnosing prostate cancer, methods for identifying a compound that modulates prostate cancer development, methods for determining the efficacy of a prostate cancer therapy, and oligonucleotide microarrays containing probes for genes involved in prostate cancer development are described.
-
Method To Determine Responsiveness Of Cancer To Epidermal Growth Factor Receptor Targeting Treatments
view source -
US Patent:7964349, Jun 21, 2011
-
Filed:Aug 20, 2007
-
Appl. No.:11/894159
-
Inventors:Daphne Winifred Bell - Arlington MA, US
Daniel A. Haber - Chestnut Hill MA, US
Pasi Antero Janne - Newton MA, US
Bruce E. Johnston - Brookline MA, US
Thomas J. Lynch - Newton MA, US
Matthew Meyerson - Concord MA, US
Juan Guillermo Paez - Boston MA, US
William R. Sellers - Chestnut Hill MA, US
Jeffrey E. Settleman - Newton MA, US
Raffaella Sordella - Bedford MA, US -
Assignee:The General Hospital Corporation - Boston MA
Dana-Farber Cancer Institute, Inc. - Boston MA -
International Classification:C12Q 1/68
-
US Classification:435 6
-
Abstract:The present invention is directed to a method for determining the responsiveness of cancer to an epidermal growth factor receptor (EGFR) treatment. In a preferred embodiment, the presence of at least one variance in the kinase domain of the erbB1 gene confers sensitivity to the tyrosine kinase inhibitor gefitinib. Thus, a diagnostic assay for these mutations will allow for the administration of gefitinib, erlotinib and other tyrosine kinase inhibitors to those patients most likely to respond to the drug.
-
Methods For Identifying And Using Snp Panels
view source -
US Patent:7981609, Jul 19, 2011
-
Filed:Jun 8, 2007
-
Appl. No.:11/811149
-
Inventors:Mark A. Rubin - Cambridge MA, US
Francesca Demichelis - Cambridge MA, US
Levi A. Garraway - Newton MA, US
William R. Sellers - Brookline MA, US -
Assignee:The Brigham and Women's Hospital, Inc. - Boston MA
Dana-Farber Cancer Institute, Inc. - Boston MA -
International Classification:C12Q 1/68
-
US Classification:435 6
-
Abstract:Described are methods for identifying single nucleotide polymorphism (SNPs) that are useful for analyzing genetic samples, and for using said SNPs to determine genetic identity of samples.
-
Method To Determine Responsiveness Of Cancer To Epidermal Growth Factor Receptor Targeting Treatments
view source -
US Patent:8105769, Jan 31, 2012
-
Filed:Aug 20, 2007
-
Appl. No.:11/894135
-
Inventors:Daphne Winifred Bell - Arlington MA, US
Daniel A. Haber - Chestnut Hill MA, US
Pasi Antero Janne - Newton MA, US
Bruce E. Johnston - Brookline MA, US
Thomas J. Lynch - Newton MA, US
Matthew Meyerson - Concord MA, US
Juan Guillermo Paez - Boston MA, US
William R. Sellers - Chestnut Hill MA, US
Jeffrey E. Settleman - Newton MA, US
Raffaella Sordella - Bedford MA, US -
Assignee:The General Hospital Corporation - Boston MA
Dana-Farber Cancer Institute, Inc. - Boston MA -
International Classification:C12Q 1/68
-
US Classification:435 6
-
Abstract:The present invention is directed to a method for determining the responsiveness of cancer to an epidermal growth factor receptor (EGFR) treatment. In a preferred embodiment, the presence of at least one variance in the kinase domain of the erbB1 gene confers sensitivity to the tyrosine kinase inhibitor gefitinib. Thus, a diagnostic assay for these mutations will allow for the administration of gefitinib, erlotinib and other tyrosine kinase inhibitors to those patients most likely to respond to the drug.
-
Method To Determine Responsiveness Of Cancer To Epidermal Growth Factor Receptor Targeting Treatments
view source -
US Patent:8465916, Jun 18, 2013
-
Filed:Aug 20, 2007
-
Appl. No.:11/894160
-
Inventors:Daphne Winifred Bell - Arlington MA, US
Daniel A. Haber - Chestnut Hill MA, US
Pasi Antero Janne - Newton MA, US
Bruce E. Johnston - Brookline MA, US
Thomas J. Lynch - Newton MA, US
Matthew Meyerson - Concord MA, US
Juan Guillermo Paez - Boston MA, US
William R. Sellers - Chestnut Hill MA, US
Jeffrey E. Settleman - Newton MA, US
Raffaella Sordella - Bedford MA, US -
Assignee:The General Hospital Corporation - Boston MA
Dana Farber Cancer Institute, Inc. - Boston MA -
International Classification:C12Q 1/68
-
US Classification:435 61
-
Abstract:The present invention is directed to a method for determining the responsiveness of cancer to an epidermal growth factor receptor (EGFR) treatment. In a preferred embodiment, the presence of at least one variance in the kinase domain of the erbB1 gene confers sensitivity to the tyrosine kinase inhibitor gefitinib. Thus, a diagnostic assay for these mutations will allow for the administration of gefitinib, erlotinib and other tyrosine kinase inhibitors to those patients most likely to respond to the drug.
-
Prostate Cancer Diagnosis And Outcome Prediction By Expression Analysis
view source -
US Patent:20060008838, Jan 12, 2006
-
Filed:Sep 6, 2005
-
Appl. No.:11/221302
-
Inventors:Todd Golub - Newton MA, US
Phillip Febbo - Jamaica Plain MA, US
Kenneth Ross - Boston MA, US
William Sellers - Chestnut Hill MA, US -
Assignee:Whitehead Institute for Biomedical Research - Cambridge MA
Dana-Farber Cancer Institute, Inc. - Boston MA -
International Classification:C12Q 1/68
-
US Classification:435006000
-
Abstract:Methods identifying prostate cancer, methods for prognosing and diagnosing prostate cancer, methods for identifying a compound that modulates prostate cancer development, methods for determining the efficacy of a prostate cancer therapy, and oligonucleotide microarrays containing probes for genes involved in prostate cancer development are described.
Googleplus
William Sellers
William Sellers
William Sellers
William Sellers
William Sellers
William Sellers
William Sellers
William Sellers
Youtube
William Sellers
view source
William Alfred Sellers
view source
William Michael Sellers
view source
William M. Sellers
view source
William Michael Sellers
view source
William F Sellers
view source
William L Sellers
view source
Bill Sellers
view sourceMyspace
Classmates
William Sellers ,Jr. (...
view sourceSchools:
Montevideo High School Penn Laird VA 1975-1979
Community:
Beverly Diehl, David Byerly, Tony Baugher, Sandra Sampson
William Sellers
view sourceSchools:
Perry Central High School New Augusta MS 1990-1994
Community:
Darlene Baker
William Glisson (Sellers)
view sourceSchools:
Glade Elementary School Laurel MS 1971-1975
William Sellers
view sourceSchools:
Cairo High School Cairo GA 1965-1969
Community:
Joyce Reeves, John Wyatt
William Sellers
view sourceSchools:
Telfair High School Mcrae GA 1968-1972
Community:
Janice Dyal, Tammy Floyd, Candy May
William Sellers
view sourceSchools:
Belmont High School Belmont MA 1993-1997
Community:
Norma Howell
William Monroy Sellers
view sourceSchools:
Mckinley High School Honolulu HI 1986-1990
William Sellers
view sourceSchools:
Palmetto High School Palmetto FL 1955-1959
Community:
Lauren Buck, Lori Earhart, Angela Decker, Melissa Cumpston
Flickr
News
T-Rex Couldn't Run—Doing So Would've Broken Its Legs
view source- We present a new approach that combines two separate biomechanical techniques to demonstrate that true running gaits would probably lead to unacceptably high skeletal loads in T-Rex, study leader William Sellers said.
- Date: Jul 18, 2017
- Category: Science
- Source: Google
Novartis looking to prime the immune system to battle cancer
view source- The company is already a leader in targeted therapies, drugs that attack specific tumors based on their genetic mutations, an effort led by Dr. William Sellers, the Cambridge-based global head of oncology research. Now, with the addition of Dranoff, who will work closely with Sellers, Novartis plans
- Date: Apr 20, 2015
- Category: Health
- Source: Google
Dinosaurs Skinnier Than Previously Thought
view source- This is a huge help for any sort of reconstruction, lead author William Sellers told Discovery News. We now have a number that suggests how much flesh to add to the bones and that should help people produce animals that are the right balance of too fat or too thin.
- Date: Jun 06, 2012
- Source: Google
Novartis launches the Cancer Cell Line Encyclopedia (CCLE) to catalogue ...
view source- on how new or existing cancer drugs might best be used in patients. "Without access to a systematically collected set of molecular data, researchers can't match experiments from cell lines with patient tumors when new medicines become available," said William Sellers, Global Head of Oncology, NIBR.
- Date: Mar 28, 2012
- Category: Health
- Source: Google
Get Report for William M Sellers from Hingham, MA, age ~55